Tianjin Lisheng Pharmaceutical Co.,Ltd. (002393.SZ)
CNY 15.64
(0.77%)
CNY 15.64
(0.77%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.13 Billion CNY | -1.43% |
| 2022 | 1.14 Billion CNY | 5.0% |
| 2021 | 1.09 Billion CNY | -4.29% |
| 2020 | 1.14 Billion CNY | -29.37% |
| 2019 | 1.61 Billion CNY | 7.43% |
| 2018 | 1.5 Billion CNY | 46.06% |
| 2017 | 1.02 Billion CNY | 21.56% |
| 2016 | 846.85 Million CNY | 9.3% |
| 2015 | 774.78 Million CNY | 0.14% |
| 2014 | 773.72 Million CNY | -25.92% |
| 2013 | 1.04 Billion CNY | -6.51% |
| 2012 | 1.11 Billion CNY | 46.28% |
| 2011 | 763.64 Million CNY | 3.48% |
| 2010 | 737.97 Million CNY | 23.88% |
| 2009 | 595.7 Million CNY | 0.53% |
| 2008 | 592.53 Million CNY | 50.66% |
| 2007 | 393.29 Million CNY | 12.55% |
| 2006 | 349.44 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 358.78 Million CNY | 52.12% |
| 2024 Q2 | 373.03 Million CNY | 3.97% |
| 2024 Q3 | 274.15 Million CNY | -25.17% |
| 2023 Q4 | 235.85 Million CNY | -7.17% |
| 2023 FY | 1.13 Billion CNY | -1.43% |
| 2023 Q1 | 335.6 Million CNY | 37.22% |
| 2023 Q2 | 321.88 Million CNY | -4.09% |
| 2023 Q3 | 254.07 Million CNY | -21.07% |
| 2022 Q1 | 306.46 Million CNY | 19.58% |
| 2022 FY | 1.14 Billion CNY | 5.0% |
| 2022 Q4 | 244.56 Million CNY | -14.87% |
| 2022 Q3 | 287.28 Million CNY | -6.81% |
| 2022 Q2 | 308.27 Million CNY | 0.59% |
| 2021 Q1 | 327.6 Million CNY | 45.34% |
| 2021 Q2 | 259.72 Million CNY | -20.72% |
| 2021 Q3 | 248.32 Million CNY | -4.39% |
| 2021 Q4 | 256.28 Million CNY | 3.2% |
| 2021 FY | 1.09 Billion CNY | -4.29% |
| 2020 Q1 | 332.67 Million CNY | -18.06% |
| 2020 Q2 | 281.18 Million CNY | -15.48% |
| 2020 Q3 | 301.57 Million CNY | 7.25% |
| 2020 Q4 | 225.4 Million CNY | -25.26% |
| 2020 FY | 1.14 Billion CNY | -29.37% |
| 2019 Q4 | 406.02 Million CNY | 14.62% |
| 2019 Q1 | 434.46 Million CNY | 7.66% |
| 2019 FY | 1.61 Billion CNY | 7.43% |
| 2019 Q3 | 354.22 Million CNY | -15.77% |
| 2019 Q2 | 420.56 Million CNY | -3.2% |
| 2018 Q4 | 403.54 Million CNY | 22.08% |
| 2018 FY | 1.5 Billion CNY | 46.06% |
| 2018 Q3 | 330.54 Million CNY | -12.02% |
| 2018 Q2 | 375.68 Million CNY | -4.61% |
| 2018 Q1 | 393.83 Million CNY | 48.16% |
| 2017 FY | 1.02 Billion CNY | 21.56% |
| 2017 Q1 | 284.98 Million CNY | 34.97% |
| 2017 Q3 | 238.15 Million CNY | -0.96% |
| 2017 Q4 | 265.81 Million CNY | 11.61% |
| 2017 Q2 | 240.46 Million CNY | -15.62% |
| 2016 FY | 846.85 Million CNY | 9.3% |
| 2016 Q1 | 236.15 Million CNY | 51.4% |
| 2016 Q3 | 178.17 Million CNY | -19.51% |
| 2016 Q2 | 221.37 Million CNY | -6.26% |
| 2016 Q4 | 211.14 Million CNY | 18.5% |
| 2015 FY | 774.78 Million CNY | 0.14% |
| 2015 Q2 | 231.49 Million CNY | -0.28% |
| 2015 Q3 | 155.16 Million CNY | -32.97% |
| 2015 Q4 | 155.97 Million CNY | 0.52% |
| 2015 Q1 | 232.14 Million CNY | 61.98% |
| 2014 Q2 | 198.35 Million CNY | -29.27% |
| 2014 Q4 | 143.31 Million CNY | -5.48% |
| 2014 Q3 | 151.61 Million CNY | -23.56% |
| 2014 Q1 | 280.42 Million CNY | 27.32% |
| 2014 FY | 773.72 Million CNY | -25.92% |
| 2013 Q3 | 225.76 Million CNY | -22.09% |
| 2013 Q2 | 289.76 Million CNY | -6.11% |
| 2013 FY | 1.04 Billion CNY | -6.51% |
| 2013 Q4 | 220.24 Million CNY | -2.44% |
| 2013 Q1 | 308.61 Million CNY | 32.16% |
| 2012 Q1 | 252.15 Million CNY | 59.47% |
| 2012 Q4 | 233.51 Million CNY | -12.77% |
| 2012 Q3 | 267.68 Million CNY | -26.4% |
| 2012 Q2 | 363.7 Million CNY | 44.24% |
| 2012 FY | 1.11 Billion CNY | 46.28% |
| 2011 Q2 | 186.06 Million CNY | -31.21% |
| 2011 Q1 | 270.48 Million CNY | 67.81% |
| 2011 Q4 | 158.12 Million CNY | 6.15% |
| 2011 FY | 763.64 Million CNY | 3.48% |
| 2011 Q3 | 148.96 Million CNY | -19.94% |
| 2010 Q2 | 168.08 Million CNY | -25.2% |
| 2010 FY | 737.97 Million CNY | 23.88% |
| 2010 Q3 | 183.98 Million CNY | 9.46% |
| 2010 Q4 | 161.18 Million CNY | -12.39% |
| 2010 Q1 | 224.71 Million CNY | 104.79% |
| 2009 Q4 | 109.72 Million CNY | -19.05% |
| 2009 Q1 | 184.47 Million CNY | 0.0% |
| 2009 Q2 | 165.95 Million CNY | -10.04% |
| 2009 FY | 595.7 Million CNY | 0.53% |
| 2009 Q3 | 135.54 Million CNY | -18.33% |
| 2008 FY | 592.53 Million CNY | 50.66% |
| 2007 FY | 393.29 Million CNY | 12.55% |
| 2006 FY | 349.44 Million CNY | 0.0% |